NLRP3 INFLAMASOME INHIBITORS
AR135554A1Pending Publication Date: 2026-09-30BIOAGE LABS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20250100779
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-16
- Filing Date
- 2025-03-25
- Publication Date
- 2026-09-30
Need to check novelty before this filing date? Find Prior Art
No text content released.
Claims
Compounds acting as NLRP3 inflammasome inhibitors; pharmaceutical compositions comprising such compounds; and methods for treating cancer and disorders associated with inflammation and age-related inflammation [inflammaging]. A compound characterized in that it is of formula (1). A compound characterized in that it is of formula (2). A compound characterized in that it is of formula (3). A pharmaceutical composition characterized in that it comprises a compound of any one of claims 1-46, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.